Previous studies have demonstrated that 5-hydroxytryptamine (5HT) released from blood platelets by bacterial endotoxin (lipopolysaccharide; LPS) requires the presence of calcium ion and plasma factor and that heparin inhibits its release (1-5).Recently, Nomura and Takagi (6) have separated the 5HT releasing factor from rabbit plasma by gel filtration on a Sephadex G-150 column. They have suggested that the plasma factor with 5HT releasing activity is a protein with a molecular wt. of approx. 110,000 and that 5HT release induced by LPS could be mediated through antagonism by LPS to the inhibitory effect of heparin on the 5HT releasing plasma factor, and also that activity of the 5HT releasing factor in plasma could be regulated by heparin and the anti-5HT releasing factor existing in the albumin fraction.
The present report describes studies on the further purification of the 5HT releasing factor in rabbit plasma and its properties.METHODS 1) Preparation of rabbit plasma: Eight rabbits of both sexes (wt. 2.0 to 3.5 kg) were used.Blood was obtained by cutting the carotid artery and mixing with 1/10 volume of 3.5 sodium citrate solution and centrifuged 1,400 g for 20 min at 4-C twice. The supernatant was pooled and used as rabbit plasma.2) Preparation of platelet suspension: Rabbit platelets isolated by similar methods previously described were suspended in 0.02 M Tris-HC1 buffer (pH 7.5) containing salt solution, the composition being as follows: NaCI, 8.33 g; KCI, 0.35 g; CaC12.2H2O, 0.37 g; MgCl2.6H2O, 0.224g; glucose, 2.O g in 1,000 ml of distilled water.3) Assay of 5HT releasing activity: Platelet suspension with or without heparin (2 units/ml) was incubated in the presence of each separated fraction of plasma factor at 37°C for 30 min under nitrogen atmosphere. Gentle shaking was employed. The mixture was then centri gufed at 1,200 g for 30 min at 4°C. Contents of 5HT in the supernatant and the pellet were determined spectrophotofluorimetrically. Methods described by Bertler (11) and Bogdanski